News

 

NEWS

AbbVie and MBC BioLabs Team Up to Support Life-Science Startups in the San Francisco Bay Area

AbbVie and MBC BioLabs Team Up to Support Life-Science Startups in the San Francisco Bay Area Read press release at CISION PR Newswire San Francisco, CA February 5, 2018 – AbbVie, a global biopharmaceutical company, and MBC BioLabs (formerly known as QB3@953), a life-science incubator, announced that they have teamed up to help support and mentor promising startups.  The partnership […]

Read more

QB3@953 Unites Life-Science Facility Under New MBC BioLabs Name

QB3@953 Unites Life-Science Facility Under New MBC BioLabs Name San Francisco, CA (February 5, 2018) – QB3@953 to become MBC BioLabs with the addition of a brand-new facility in San Carlos. QB3@953, an independent provider of innovative shared laboratory space located at 953 Indiana St. in San Francisco, was born out of the California Institute for Quantitative Biosciences, a three-campus […]

Read more

We Welcome Provenance Biofabrics

We Welcome Provenance Biofabrics Provenance Biofabrics is harnessing breakthroughs in tissue engineering and synthetic biology to make the next generation of leather. By synthesizing and programming collagen, the building block of skin, they are working to reinvent our oldest consumer material, sustainably and with no animals harmed.

Read more

We Welcome Mammoth Diagnostics

We Welcome Mammoth Diagnostics Mammoth Diagnostics is an early stage startup founded by Stanford PhDs that is developing the next generation diagnostics platform using recent advances in CRISPR technology. They are enabling everyone to have access to rapid, low cost, and easy to use tests for identifying DNA and RNA sequences. Their initial market focus is infectious disease testing, but […]

Read more

MBC BioLabs’ New Site is Center of San Carlos Life-science Growth

MBC BioLabs’ New Site is Center of San Carlos Life-science Growth Read online article at www.smdailyjournal.com Biotech blooms in San Carlos New incubator, office acquisition in industrial area signal shift toward science By Anna Schuessler, Daily Journal staff After more than 1 million square feet in San Carlos office space was acquired by a real estate group known for leasing […]

Read more

We Welcome Aether

We Welcome Aether Aether empowers researchers to make history with the first 3D bioprinter truly capable of printing structures with tissue-scale complexity.   Karen Dubbin, Science Director of Aether, here with Douglas Crawford receiving a bottle of champagne for completing an experiment on their first day!

Read more

Naked Biome Entering Clinical Trials to Target Propionibacterium Acnes

Naked Biome Entering Clinical Trials to Target Propionibacterium Acnes Naked Biome is developing a probiotic therapy for acne. Instead of killing P. acnes, the QB3@953 startup, would have patients flood their faces with live, healthy strains of bacterium, ensuring the good bacterial will outcompete the bad. Full Scientific American Article

Read more

Pionyr Immunotherapeutics Completes $62M Series B Financing to Advance Antibody-based Therapeutics Targeting the Tumor Microenvironment

Pionyr Immunotherapeutics Completes $62M Series B Financing to Advance Antibody-based Therapeutics Targeting the Tumor Microenvironment Max Krummel, PhD, Pionyr Co-Founder and Robert E. Smith Endowed Chair in Experimental Pathology, UCSF Pionyr Immunotherapeutics, a company at QB3@953, is developing antibody therapeutics that increase the body’s antitumor immunity by rebalancing the myeloid infiltrate in the tumor microenvironment, announced the closing of a […]

Read more

We Welcome Engine Biosciences

Engine Biosciences is a venture-backed technology company integrating experimental biology and data science to map and decipher complex biological networks for more effective and efficient drug discovery. Engine’s technologies culminate from several years of research by our scientific founders who include faculty members of MIT, Harvard, Mayo Clinic, and UCSD, and our leadership team is applying our previous successful company […]

Read more

Asilomar Bio and Koch Biological Solutions Agree to Exclusive Commercial License of Leading Yield Enhancement Technology

Asilomar Bio and Koch Biological Solutions Agree to Exclusive Commercial License of Leading Yield Enhancement Technology QB3@953 startup, Asilomar has developed a small molecule to improve plant stress response. Koch Biological Solutions, LLC has secured exclusive global rights to commercialize and market products containing Asilomar Bio’s flagship yield enhancement technology for foliar, in-furrow, and other modes of application on a […]

Read more
Page 3 of 1212345...10...Last »

Upcoming Event

  • A Welcome Party for Newcomers! Location: 953 Indiana Street, San Francisco

    15:30-17:00
    08/31/2018
    Please join us for a celebration to welcome all new companies to the MBC BioLabs family! Come and meet the new faces in the building and enjoy some food!

Address

953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287
Map

Sign-Up for our Newsletter